Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
7 hedge funds and large institutions have $2M invested in Enzo Biochem, Inc. in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 36 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
19.98% less ownership
Funds ownership: 25.61% → 5.63% (-20%)
60% less capital invested
Capital invested by funds: $4.96M → $2M (-$2.96M)
83% less funds holding
Funds holding: 41 → 7 (-34)
94% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 36
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
+$831K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$7.65K |
| 3 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$4.44K |
| 4 |
Squarepoint
New York
|
+$4.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
-$1.92M |
| 2 |
Renaissance Technologies
New York
|
-$770K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$688K |
| 4 |
BlackRock
New York
|
-$354K |
| 5 |
MBAM
Mink Brook Asset Management
West Palm Beach,
Florida
|
-$299K |
ENZ Hedge Fund Activity: Q2 2025 in Review
7 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2025, worth a combined $2M — down 60% from $4.96M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of ENZ and 2 opened new positions — a net loss of 34 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was ODDO BHF Asset Management, opening a new position worth an estimated $831K. The largest seller was Harbert Fund Advisors, exiting entirely with an estimated $1.92M sold.
- 7 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2025, down from 41 in Q1 2025.
- Funds reported $2M of Enzo Biochem, Inc. stock for Q2 2025, down 60% quarter-over-quarter.
- 2 funds opened new Enzo Biochem, Inc. positions in Q2 2025 and 36 closed out, a net change of -34 holders.
- The largest Enzo Biochem, Inc. buyer in Q2 2025 was ODDO BHF Asset Management, an estimated $831K added.
- The largest Enzo Biochem, Inc. seller in Q2 2025 was Harbert Fund Advisors, an estimated $1.92M sold.
Based on aggregated 13F filings for Q2 2025.